These compounds alone or in combinations are of common use in clinical practice and may be useful for the treatment of PKAN patients with residual enzyme expression levels
Environ Toxicol 35(6):683
This product is presented strictly for research use only and is not intended for human use, animal use, diagnosis, treatment, prevention, consumption, cosmetic use, skin use, anti-aging use, performance use, recovery use, or personal application
They also use the popular glutathione supplier Sertia mixed in the BioGlute liposomal proprietary blend
Danuglipron: the discontinued competitor Pfizer was developing danuglipron, another small-molecule oral GLP-1 agonist